stockrow
Friday 6 November 2026
Export PCVX’s income statement to Excel — free account
Vaxcyte, Inc.
PCVX Healthcare Biotechnology
- EPS
- −61.5%
- Free cash flow
- −92.6%
Quarter to June 2026, against a year earlier
63.83
1.91
+3.08%
Follow PCVX
Alert me
Vaxcyte, Inc. (PCVX) Current ratio
Vaxcyte, Inc.'s current ratio at the end of the quarter to 30 June 2026 was 5.7×, down 2.2× from fiscal 2025 (7.9×). Over the past ten years it has ranged from 5.6× (fiscal 2019) to 23.3× (fiscal 2022); the current reading is higher than 38% of that period. That is above the Biotechnology industry median of 4.9× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 7.9× | (37.99%) |
| FY2024 | 12.8× | 69.15% |
| FY2023 | 7.5× | (67.58%) |
| FY2022 | 23.3× | 160.54% |
| FY2021 | 8.9× | 7.54% |
| FY2020 | 8.3× | 48.64% |
| FY2019 | 5.6× | (43.77%) |
| FY2018 | 9.9× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 5.7× | (23.60%) |
| Mar 2026 | 7.5× | (5.29%) |
| Dec 2025 | 7.9× | (10.46%) |
| Sep 2025 | 8.8× | (20.46%) |
| 24 more quarters | Free account |
Against its own ten years
Low 5.6×
High 23.3×
Ten-year median
8.6×
Current reading's percentile
38
Current ratio against peers
| Company | Current ratio |
|---|---|
| PTGX Protagonist Therapeutics, Inc. compare | 21.7× |
| CAI Caris Life Sciences,�Inc. compare | 6.7× |
| PCVX Vaxcyte, Inc. | 5.7× |
| IBRX ImmunityBio, Inc. compare | 5.7× |
| TECH Bio-Techne Corp compare | 4.5× |
| TGTX TG Therapeutics, Inc. compare | 4.3× |
| MDGL Madrigal Pharmaceuticals, Inc. compare | 3.1× |
| TWST Twist Bioscience Corporation compare | 2.7× |
| BMRN BioMarin Pharmaceutical Inc. compare | 2.4× |
| Biotechnology industry median | 4.9× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)